China Regenerative Medicine International Ltd
China Regenerative Medicine International Ltd (CRMI), an investment holding company, is one of the top biotech companies in Hong Kong. It was formerly known as China Bio-Med Regeneration Technology Ltd and then renamed to China Regenerative Medicine International Ltd (CRMI) in March 2015. It was set up in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong. It principally participates in R&D, production and distribution of bio-medical and healthcare products, consists of Cellular Therapy, Tissue Engineering Bio-Medical Devices, Cosmetics & Healthcare Products, Medical Equipment & Other Services.
CRMI engages in the research and development of bio-medical and healthcare products, as well as medical techniques. It is organized through Cell Products and Services, Cosmetic Products and Services, and Healthcare Products and Services segments. This company brings to its clients health management services comprising assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. Besides that, skincare and cosmetic products, including facial and eye creams, serums, moisturizing spray, tonic water, etc., are also provided under the Ascara brand.
With a view to improving human health, CRMI noticeably pay close attention to the demands of patients, and improve modern high technology to benefit the public, so as to meet the customers' expectations.
Founded: 2001
Headquarters: Tsim Sha Tsui, Hong Kong
Website: http://www.crmi.hk
